Tags: Hepatitis B
Gaps in Hepatitis B Evaluation and Treatment
G&H What is the typical evaluation process for hepatitis B? CC At the first clinic visit, the provider will confirm the diagnosis of hepatitis B and […]
Review of Updated Hepatitis B Vaccine Recommendations and Potential Challenges With Implementation
Abstract: Hepatitis B virus (HBV) infection is a vaccine-preventable disease associated with substantial morbidity and mortality. Although safe and effective hepatitis B vaccines are available, an […]
Cessation of Nucleoside/Nucleotide Analogue Therapy in Chronic Hepatitis B HBeAg-Negative Patients
Abstract: Most patients treated for chronic hepatitis B infection require lifelong treatment with nucleoside/nucleotide analogues (NAs), which inhibit hepatitis B virus (HBV) replication but do not […]
Screening for Hepatitis B Virus and Tuberculosis
G&H Currently, how common is coinfection of hepatitis B virus and tuberculosis (active or latent) in the United States? AC It is challenging to assess estimates […]
Using Immunomodulatory and Antiviral Strategies in the Quest to Cure Hepatitis B Virus Infection
G&H What should be the endpoint of hepatitis B virus treatment? AG This is an important question. Several meetings were convened by the European Association for […]
Gastro-Hep News
US Preventive Services Task Force Reaffirms Hepatitis B Virus Screening in Pregnant Women All pregnant women should still b8e screened for hepatitis B virus (HBV) infection […]
Gastro-Hep News
Liquid Biopsies Show Potential in Detecting Early-Stage Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection Liquid biopsies, based on a combination of cell-free DNA (cfDNA) […]
Elimination of Hepatitis B and C Virus Infections
G&H Is it feasible to eliminate hepatitis B and C virus infections in the United States? AA Hepatitis B virus (HBV) and hepatitis C virus (HCV) […]
Gastro-Hep News
US Food and Drug Administration Approves Infliximab Biosimilar On December 14, 2017, the US Food and Drug Administration (FDA) approved the infliximab (Remicade, Janssen) biosimilar infliximab-qbtx […]
Gastro-Hep News
US Food and Drug Administration Approves Infliximab Biosimilar On April 21, 2017, the US Food and Drug Administration (FDA) approved infliximab-abda (Renflexis, Samsung Bioepis), an infliximab […]
A Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women
Abstract: Mother-to-child transmission (MTCT) of hepatitis B virus (HBV) remains high even with the proper use of active-passive immunoprophylaxis in newborns. Mothers with significant viremia […]
Highlights in Hepatitis B Virus Treatment From the 2016 Annual Meeting of the American Association for the Study of Liver Diseases
From the 2016 Annual Meeting of the American Association for the Study of Liver Diseases November 11-15, 2016 • Boston, Massachusetts Tenofovir Alafenamide Is […]
Evolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection
Abstract: Is a cure for chronic hepatitis B virus (HBV) infection possible? Hepatitis C virus infection is now routinely cured medically. There is a growing expectation […]